FAM20C is identified as a key mediator of obesity-induced adipocyte dysfunction and inflammation, suggesting its inhibition as a potential therapy for type 2 diabetes. The gene discussed is FAM20C; the disease is obesity due to melanocortin 4 receptor deficiency.